Yousif Capital Management’s BioNTech BNTX Stock Holding History

Yousif Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,653	Closed	-$434K	–	1920
2024 Q3	$434K	Sell	3,653 -133	-4%	-$12.2K	﹤0.01%	1559
2024 Q2	$304K	Sell	3,786 -170	-4%	-$15.5K	﹤0.01%	1685
2024 Q1	$365K	Buy	3,956 +60	+2%	+$5.75K	﹤0.01%	1659
2023 Q4	$411K	Hold	3,896	–	–	﹤0.01%	1626
2023 Q3	$423K	Sell	3,896 -175	-4%	-$19.4K	0.01%	1562
2023 Q2	$439K	Hold	4,071	–	–	0.01%	1542
2023 Q1	$507K	Hold	4,071	–	–	0.01%	1486
2022 Q4	$612K	Hold	4,071	–	–	0.01%	1405
2022 Q3	$549K	Buy	4,071 +350	+9%	+$53.5K	0.01%	1469
2022 Q2	$555K	Sell	3,721 -20	-0.5%	-$3.06K	0.01%	1502
2022 Q1	$638K	Hold	3,741	–	–	0.01%	1539
2021 Q4	$964K	Buy	+3,741	New	+$1.02M	0.01%	1388

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Yousif Capital Management's BNTX Position: Q4 2024 in Review

Yousif Capital Management sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 3,653 shares — an estimated $434K sold.

Yousif Capital Management first reported a position in BNTX in Q4 2021 and held it in 12 quarters. The position peaked at $964K in Q4 2021. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

Yousif Capital Management reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
Yousif Capital Management sold 3,653 BioNTech shares in Q4 2024, an estimated $434K.
Yousif Capital Management first reported a position in BioNTech in Q4 2021 and held it in 12 quarters.
Yousif Capital Management's BioNTech position peaked at $964K in Q4 2021.
303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Yousif Capital Management's 13F filing for Q4 2024, filed 27 Jan 2025.